Back to results
US 2019/0336441 A1Published application
Method for treating atrophic age related macular degeneration
AssigneeAllergan, Inc.
InventorsScott M. Whitcup, Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, James A. Burke
Life of this patent
Estimating the term…
Abstract
Compositions and methods for treating dry age related macular degeneration (dry AMO) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
Claims13
A low dose method for preventing development of ocular neovascularization, the method comprising the steps of:
- (a) preparing a biocompatible, sustained release drug delivery system comprising an anti-neovascular drug, wherein the anti-neovascular drug is associated with a polymeric vehicle, and;
- (b) injecting the drug delivery system into an intraocular location in a patient in need thereof, thereby preventing the development of ocular neovascularization.
Dependencies are inferred from the claim text.